Answers are grounded in this paper and cite their sources.
Background and Objectives: Liver Imaging Reporting and Data System treatment response (LR-TR) algorithm has been developed to evaluate response after locoregional treatment (LRT) in patients with hepatocellular carcinoma (HCC). The aim of the study was to corroborate if the post-treatment radiological findings described using LR-TR correspond to the final histopathological results, and survival in relation to different LR-TR groups in patients underwent LRT before liver transplantation (LT). Methods: A retrospective single-center study was performed. Data of patients undergoing LT and LRT due to HCC between January 2010 and December 2022 were collected. Results: Four hundred and four patients were transplanted, of which 103 (25.5%) had HCC. Ninety-seven patients (93.2%) received LRT. 53% of treated patients had a complete response on pathological examination. Re-evaluation imaging was performed in 88 patients. 59% were classified as non-viable LR-TR, 32.5% as viable LR-TR, and 8.5% as equivocal LR-TR. Regarding the correlation between the degree of tumor necrosis and the post-treatment LR-TR category, 37% of patients evaluated as viable LR-TR had a “complete response” compared to 62.9% with “no complete response”. For those evaluated as non-viable LR-TR, 59.2% had a “complete response” compared to 40.8% with a “no complete response” (P = 0.123). There were no statistically significant differences in overall and disease-free survival between the viable LR-TR, non-viable LR-TR, and equivocal LR-TR groups (P = 0.3484 and P = 0.4152, respectively). Conclusion: We have not been able to establish whether radiological response correlates with anatomopathological outcomes, as well as survival in these groups. More prospective studies are needed to validate these findings.
No takes yet. Share an insight, caveat, or question.
Chairi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: